A detailed history of Ascent Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ascent Wealth Partners, LLC holds 59,261 shares of ABBV stock, worth $10.5 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
59,261
Previous 59,855 0.99%
Holding current value
$10.5 Million
Previous $10.3 Million 13.99%
% of portfolio
1.64%
Previous 1.5%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $97,320 - $118,402
-594 Reduced 0.99%
59,261 $11.7 Million
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $63,154 - $73,750
-408 Reduced 0.68%
59,855 $10.3 Million
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $21,415 - $24,401
134 Added 0.22%
60,263 $11 Million
Q4 2023

Jan 22, 2024

BUY
$137.6 - $154.97 $95,769 - $107,859
696 Added 1.17%
60,129 $9.32 Million
Q3 2023

Oct 20, 2023

SELL
$133.59 - $154.65 $84,696 - $98,048
-634 Reduced 1.06%
59,433 $8.86 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $741,658 - $922,945
5,597 Added 10.28%
60,067 $8.09 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $116,989 - $134,730
809 Added 1.51%
54,470 $8.68 Million
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $130,841 - $156,913
-946 Reduced 1.73%
53,661 $8.68 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $483,290 - $554,301
-3,601 Reduced 6.19%
54,607 $7.33 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $8.18 Million - $10.4 Million
-59,415 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $329,818 - $409,211
2,499 Added 4.39%
59,415 $9.63 Million
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $279,962 - $354,233
-2,606 Reduced 4.38%
56,916 $7.71 Million
Q3 2021

Nov 01, 2021

SELL
$106.4 - $120.78 $96,717 - $109,789
-909 Reduced 1.5%
59,522 $6.42 Million
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $25,671 - $28,599
244 Added 0.41%
60,431 $6.81 Million
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $123,169 - $135,594
1,204 Added 2.04%
60,187 $6.51 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $18,351 - $24,776
228 Added 0.39%
58,983 $6.32 Million
Q3 2020

Oct 22, 2020

BUY
$85.91 - $100.83 $95,703 - $112,324
1,114 Added 1.93%
58,755 $5.15 Million
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $88,337 - $118,208
1,204 Added 2.13%
57,641 $5.66 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $25,993 - $39,409
403 Added 0.72%
56,437 $4.3 Million
Q4 2019

Jan 29, 2020

SELL
$72.13 - $90.25 $6,563 - $8,212
-91 Reduced 0.16%
56,034 $4.96 Million
Q3 2019

Oct 22, 2019

BUY
$62.98 - $75.72 $30,986 - $37,254
492 Added 0.88%
56,125 $4.25 Million
Q2 2019

Jul 30, 2019

BUY
$65.7 - $83.98 $57,159 - $73,062
870 Added 1.59%
55,633 $4.04 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $254,407 - $299,425
3,298 Added 6.41%
54,763 $4.41 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $77 - $96
1 Added 0.0%
51,465 $4.75 Million
Q3 2018

Aug 21, 2019

BUY
$88.91 - $98.84 $105,625 - $117,421
1,188 Added 2.36%
51,464 $4.87 Million
Q2 2018

Aug 21, 2019

BUY
$89.78 - $106.23 $104,952 - $124,182
1,169 Added 2.38%
50,276 $4.66 Million
Q1 2018

Aug 21, 2019

SELL
$92.01 - $123.21 $7,728 - $10,349
-84 Reduced 0.17%
49,107 $4.65 Million
Q4 2017

Aug 21, 2019

BUY
$89.56 - $98.21 $33,943 - $37,221
379 Added 0.78%
49,191 $4.76 Million
Q3 2017

Aug 21, 2019

SELL
$69.85 - $89.22 $9,779 - $12,490
-140 Reduced 0.29%
48,812 $4.34 Million
Q2 2017

Aug 21, 2019

SELL
N/A
-450 Reduced 0.91%
48,952 $3.55 Million
Q1 2017

Aug 21, 2019

BUY
N/A
460 Added 0.94%
49,402 $3.22 Million
Q4 2016

Aug 21, 2019

BUY
N/A
69 Added 0.14%
48,942 $3.07 Million
Q3 2016

Aug 21, 2019

SELL
N/A
-138 Reduced 0.28%
48,873 $3.08 Million
Q2 2016

Aug 21, 2019

BUY
N/A
260 Added 0.53%
49,011 $3.03 Million
Q1 2016

Aug 21, 2019

BUY
N/A
515 Added 1.07%
48,751 $2.79 Million
Q4 2015

Aug 21, 2019

BUY
N/A
710 Added 1.49%
48,236 $2.85 Million
Q3 2015

Aug 21, 2019

BUY
N/A
360 Added 0.76%
47,526 $2.59 Million
Q2 2015

Aug 21, 2019

BUY
N/A
525 Added 1.13%
47,166 $3.17 Million
Q1 2015

Aug 21, 2019

BUY
N/A
15,590 Added 50.21%
46,641 $2.73 Million
Q4 2014

Aug 21, 2019

BUY
N/A
804 Added 2.66%
31,051 $2.03 Million
Q3 2014

Aug 21, 2019

BUY
N/A
65 Added 0.22%
30,247 $1.75 Million
Q2 2014

Aug 21, 2019

BUY
N/A
615 Added 2.08%
30,182 $1.7 Million
Q1 2014

Aug 22, 2019

BUY
N/A
445 Added 1.53%
29,567 $1.52 Million
Q4 2013

Aug 22, 2019

BUY
N/A
29,122
29,122 $1.54 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ascent Wealth Partners, LLC Portfolio

Follow Ascent Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Wealth Partners, LLC with notifications on news.